Cancer

Study finds way to potentially improve immunotherapy for cancer

A new study has identified a drug that potentially could make a common type of immunotherapy for cancer even more effective. The study in laboratory mice found that the drug dasatinib, which is FDA-approved to treat certain ...

Medical research

A ratiometric fluorescent probe for cisplatin

NUS chemists have developed a novel ratiometric fluorescent probe for studying cellular activity of the clinically important anticancer drug cisplatin for next generation drug development.

Cancer

Advancing therapy by measuring the 'games' cancer cells play

Despite rapid advances in targeted therapies for cancer, tumors commonly develop resistance to treatment. When resistance emerges, tumor cells continue to grow unchecked, despite all attempts to slow cancer progression. While ...

page 1 from 26